rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Haemonetics Corporation

HAE · NYSE

Health CareMedical DevicesLeading

HAE stood above a rising 150-day average in 27 of the last 52 weekly readings, including each of the last 11 weeks. It is 44.4% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−4 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
11 in a row
Industry in uptrend
29% -4 in 4 wk
Insider buys, 12 months
$99K
Insider sales, 12 months
$0
Officials’ trades on record
17
Institutions holding
297 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 27 of 52 weeks.

22 Apr – 21 Oct
15%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$95KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

17 disclosed lines: House 17, Senate 0, executive 0; 4 people.

WhoDidAmountTraded
Lois Frankel House: U.S. House ClerkFL21sold$1k–$15k7 May 2021filed 25 May 2021
Lois Frankel House: U.S. House ClerkFL21sold$1k–$15k6 May 2021filed 25 May 2021
Josh Gottheimer House: U.S. House ClerkNJ05sold$1k–$15k25 Jan 2021filed 9 Feb 2021
Josh Gottheimer House: U.S. House ClerkNJ05bought$1k–$15k16 Oct 2020filed 5 Nov 2020
Josh Gottheimer House: U.S. House ClerkNJ05sold$1k–$15k15 Sep 2020filed 13 Oct 2020
Lois Frankel House: U.S. House ClerkFL21bought$1k–$15k14 Aug 2020filed 24 Aug 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k1 Jun 2020filed 16 Jun 2020
Josh Gottheimer House: U.S. House ClerkNJ05bought$1k–$15k28 May 2020filed 10 Jun 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k19 May 2020filed 16 Jun 2020
Josh Gottheimer House: U.S. House ClerkNJ05bought$1k–$15k15 May 2020filed 10 Jun 2020
Lois Frankel House: U.S. House ClerkFL21sold$1k–$15k7 Aug 2018filed 24 Aug 2018
Lois Frankel House: U.S. House ClerkFL21sold$1k–$15k14 Jun 2018filed 22 Jun 2018

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders297+6 on the quarter
New · exited54 · 48
Reported value$3.6B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20265,909,258$443.2M+289,279+5.1%
NEUBERGER BERMAN GROUP LLCadded · filed 13 Aug 20264,179,443$313.5M+618,525+17.4%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20262,546,394$191.0M-12,922−0.5%
AQR CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 20262,266,489$165.0M-1,090,054−32.5%
ARIEL INVESTMENTS, LLCnew · filed 14 Aug 20262,060,966$154.6M+2,060,966
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20262,059,578$154.5M-30,811−1.5%
STATE STREET CORPadded · filed 7 Aug 20261,818,186$136.4M+45,288+2.6%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,585,222$118.9M+259,165+19.5%
CITADEL ADVISORS LLCadded · filed 14 Aug 20261,510,120$113.3M+1,251,967+485.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,287,240$96.6M+68,262+5.6%
31 Mar 2023 – 30 Jun 2026
249273296Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Claire Pomeroy Company insiderDirector · last 24 Jul 20260 · 0
Diane M. Bryant Company insiderDirector · last 24 Jul 20260 · 0
Ellen M. Zane Company insiderDirector · last 24 Jul 20260 · 0
Lloyd Emerson Johnson Company insiderDirector · last 24 Jul 20260 · 0
Mark W. Kroll Company insiderDirector · last 24 Jul 20261 · 10
Martin D. Madaus Company insiderDirector · last 24 Jul 20260 · 0
Michael J. Coyle Company insiderDirector · last 24 Jul 20260 · 0
Robert E. Abernathy Company insiderDirector · last 24 Jul 20261 · 0
Farris Maryanne Maunsell Company insiderVP, Chief Accounting Officer · last 5 Jun 20260 · 0
Laurie A. Miller Company insiderSVP, Human Resources · last 5 Jun 20260 · 6
Christopher Simon Company insiderPresident & CEO · last 15 May 20261 · 21
Frank Chan Company insiderEVP, Chief Operating Officer · last 15 May 20260 · 0

Same industry

RCEL Avita MedicalLeading+127%
HTFL HeartflowLeading+59%
ATRC AtriCureLeading+51%
BVS BioventusLeading+24%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2026 · to 28 Mar 202659.0%
Operating profit marginFY 2026 · to 28 Mar 202611.7%
Free cash flow marginFY 2026 · to 28 Mar 202619.5%
Return on capital employedFY 2026 · to 28 Mar 20267.4%
Cash conversionFY 2026 · to 28 Mar 2026301%
Debt to equityFY 2026 · to 28 Mar 20261.56×
Interest coverFY 2026 · to 28 Mar 20268.12×
Research spendFY 2026 · to 28 Mar 20264.5%
Share count trendFY 2026 · to 15 May 20260.4%
Cash and equivalentsFY 2026 · to 28 Mar 2026$245.4M
Free cash flowFY 2026 · to 28 Mar 2026$260.4M

Analyst forecasts

No analyst forecasts yet.